Value
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 3.7 |
| P/S | 6.8 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 4.5 |
| PEG | 3.2 |
| Analyst target | 5.0 |
- ▸Forward P/E: 27.6x
- ▸PEG: 3.88
BCPC · Why this verdict
Why Balchem (BCPC) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.3/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
At a forward multiple of 26.8 times and a price-to-growth ratio of 3.76, the stock screens expensive relative to both absolute thresholds and peers; the value score of 4.0 out of 10 reflects a meaningful premium that the business must grow into, and at these multiples the margin for error is narrow. Valuation breakdown | The forward multiple compresses below 22 times — either through price decline or earnings growth — over the next 12 months, bringing the valuation closer to a level that offers a more reasonable entry point. | →Stable |
| CounterBest-in-class margins and a perfect Piotroski score are characteristics that typically command a sustained premium to the peer group; if quality remains high, the current multiple may prove durable rather than mean-reverting. | ||
The company achieved a perfect Piotroski financial strength score of 9 out of 9 — signaling simultaneous strength across profitability, leverage, and operating efficiency — and carries a moat score of 7.0 and best-in-class margins relative to peers; this quality profile suggests a durable business capable of sustaining above-average returns through a cycle. Quality breakdown | Piotroski score remains at 8 or above for at least 3 consecutive reported quarters, confirming that the current quality readings reflect structural business strength rather than a temporary peak. | →Stable |
| CounterA perfect Piotroski score is by definition a high-water mark that can only stay constant or decline from here; any single deterioration in operating cash flow, leverage ratios, or asset turnover would reduce the score and could signal that the quality peak has passed. | ||
The company beat earnings estimates in three of the last four quarters — with an in-line result in the most recent period — maintaining a track record of at least matching consensus without any outright misses; while positive surprises have been modest at roughly 2% on average, the absence of misses reflects disciplined execution against guidance. Earnings | The in-line streak does not extend further — the company returns to outright beats in the next 2 quarters with positive surprises above 2% — confirming the delivery track record remains intact. | →Stable |
| CounterThe most recent quarter came in exactly in line with zero surprise, and if this marks the start of a plateau in per-share earnings growth, the beat streak may have peaked; a forward multiple above 26 times leaves very little margin for even modest execution shortfalls. | ||
With only 4.3% headroom to the take-profit target of $170.64 and a reward-to-risk ratio of roughly 1-to-1, the current setup does not offer sufficient asymmetry to compensate for the risk of holding a name trading at a demanding valuation; the asymmetry gate has failed, indicating the entry point is unfavorable even for a high-quality business. Warnings | Analyst price target upgrades push the take-profit level above $185, restoring more than 13% upside from the current price and re-establishing a constructive risk/reward setup. | →Stable |
| CounterFor a high-quality compounder with consistent delivery, a thin near-term upside to a single analyst-derived target may understate the long-run return potential; patient holders who ignore the near-term geometry may be rewarded as earnings compound through the premium multiple. | ||
At a forward multiple of 26.8 times and a price-to-growth ratio of 3.76, the stock screens expensive relative to both absolute thresholds and peers; the value score of 4.0 out of 10 reflects a meaningful premium that the business must grow into, and at these multiples the margin for error is narrow.
→StableValuation breakdown
- Expectation
- The forward multiple compresses below 22 times — either through price decline or earnings growth — over the next 12 months, bringing the valuation closer to a level that offers a more reasonable entry point.
CounterBest-in-class margins and a perfect Piotroski score are characteristics that typically command a sustained premium to the peer group; if quality remains high, the current multiple may prove durable rather than mean-reverting.
The company achieved a perfect Piotroski financial strength score of 9 out of 9 — signaling simultaneous strength across profitability, leverage, and operating efficiency — and carries a moat score of 7.0 and best-in-class margins relative to peers; this quality profile suggests a durable business capable of sustaining above-average returns through a cycle.
→StableQuality breakdown
- Expectation
- Piotroski score remains at 8 or above for at least 3 consecutive reported quarters, confirming that the current quality readings reflect structural business strength rather than a temporary peak.
CounterA perfect Piotroski score is by definition a high-water mark that can only stay constant or decline from here; any single deterioration in operating cash flow, leverage ratios, or asset turnover would reduce the score and could signal that the quality peak has passed.
The company beat earnings estimates in three of the last four quarters — with an in-line result in the most recent period — maintaining a track record of at least matching consensus without any outright misses; while positive surprises have been modest at roughly 2% on average, the absence of misses reflects disciplined execution against guidance.
→StableEarnings
- Expectation
- The in-line streak does not extend further — the company returns to outright beats in the next 2 quarters with positive surprises above 2% — confirming the delivery track record remains intact.
CounterThe most recent quarter came in exactly in line with zero surprise, and if this marks the start of a plateau in per-share earnings growth, the beat streak may have peaked; a forward multiple above 26 times leaves very little margin for even modest execution shortfalls.
With only 4.3% headroom to the take-profit target of $170.64 and a reward-to-risk ratio of roughly 1-to-1, the current setup does not offer sufficient asymmetry to compensate for the risk of holding a name trading at a demanding valuation; the asymmetry gate has failed, indicating the entry point is unfavorable even for a high-quality business.
→StableWarnings
- Expectation
- Analyst price target upgrades push the take-profit level above $185, restoring more than 13% upside from the current price and re-establishing a constructive risk/reward setup.
CounterFor a high-quality compounder with consistent delivery, a thin near-term upside to a single analyst-derived target may understate the long-run return potential; patient holders who ignore the near-term geometry may be rewarded as earnings compound through the premium multiple.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Balchem Corporation is a high-quality specialty chemicals business — a perfect Piotroski score of 9 out of 9, a moat score of 7.0, and best-in-class margins — with a consistent earnings delivery record, but the stock screens expensive at a forward multiple of 26.8 times and offers only 4.3% headroom to the take-profit target, leaving the risk/reward insufficient to justify a new position at current levels.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 4.2 |
| ROA | 5.4 |
| Gross margin | 3.3 |
| Op margin | 8.4 |
| Net margin | 7.5 |
| Current ratio | 8.6 |
| FCF quality | 6.4 |
| Moat | 7.0 |
| Piotroski F | 10.0 |
- ▸Strong Piotroski F-Score: 9/9
Growth
4.3/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.5 |
| EPS growth | 4.1 |
Momentum
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 5.1 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 7.7 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 20%
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
3.9/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.3 |
| quality rank | 7.5 |
| growth rank | 5.7 |
- ▸Best-in-class margins
Technical
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.1 |
| support resistance | 4.3 |
| 52w position | 8.2 |
| gap | 6.0 |
Risk (lower is worse)
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 9.1 |
| days to cover | 8.7 |
| volatility | 7.1 |
| put call | 6.7 |
| implied vol | 2.2 |
| beta | 8.1 |
| debt equity | 9.4 |
- ▸High IV: 67%
Catalyst
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 3.6 |
| dividend safety | 7.0 |
- ▸Strong earnings: 3B/0M
- ▸Dividend: 57.0%
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:6.1>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:24d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.4<1.5@spot
Warning (0)
none
Reward-to-Risk
0.38
Upside
+2.2%
Downside
5.7%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 57, MACD bullish
EdgeCatalyst-Driven — Earnings in 24d with 3/4 beat streak
SuitabilityModerate — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 5.3 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Risk (lower is worse) at 7.3) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.4<1.5@spot) reinforce the read. Current asymmetry R:R is 0.38 — supplementary context, not the trigger for this path.
The strongest dimensions are Risk (lower is worse) at 7.3, Quality at 6.8, and Momentum at 6.1; the weakest are Peer rank at 3.9, Value at 3.9, and Growth at 4.3. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 0.38 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1High Quality Piotroski Perfect Score
Trip ifPiotroski score falls below 7 out of 9 for 2 consecutive reported quarters.
- P2Consistent Earnings Delivery
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P3Expensive Valuation Screens
Trip ifForward price-to-earnings multiple compresses below 22 times based on next-twelve-months consensus estimates.
- P4Thin Upside Insufficient Asymmetry
Trip ifAnalyst consensus price target rises above $185.00, restoring more than 13% upside from the current $163.68 price.